A detailed history of Newbridge Financial Services Group, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 1,000 shares of ADMA stock, worth $16,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$16,379
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$15.62 - $22.62 $15,620 - $22,620
1,000 New
1,000 $17,000
Q2 2024

Sep 11, 2024

BUY
$5.98 - $11.18 $5,980 - $11,180
1,000 New
1,000 $11,000
Q4 2021

Jan 19, 2022

SELL
$1.09 - $1.66 $50,194 - $76,443
-46,050 Closed
0 $0
Q3 2021

Oct 27, 2021

BUY
$1.13 - $1.65 $52,036 - $75,982
46,050 New
46,050 $52,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.22B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.